aparoscopic band-separated mini-gastric bypass

Not Applicable

Completed

• Conditions: Morbid obesity; Nutritional, Metabolic, Endocrine

• Registration Number: ISRCTN56106651
• Lead Sponsor: The Society of Bariatric and Metabolic Surgeons of Kazakhstan

Brief Summary

2019 results in https://pubmed.ncbi.nlm.nih.gov/31654345/ (added 28/05/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2016-01-06
• Study Completion: 2017-01-22
• Last Update Posted: 8 June 2020

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 80

Inclusion Criteria

Obese patients:
1. aged between 18 and 60
2. with American Society of Anesthesiologists (ASA) physical status of I or II
3. BMI = 35

Exclusion Criteria

Obese patients with BMI = 60 kg/m2.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<br> 1. Weight loss, measured by body weight in kg (BMI – body mass index kg/m 2) and waist circumference before and after surgery and also the percentage of excess weight loss (%EWL) (at 6 months and then 12 months after surgery)<br> 2. Changes in co-morbidities by evaluation of symptoms: diabetes improved or resolved in % of patients, hyperlipidemia improved in %, hypertension improved or resolved in %, and obstructive sleep apnea improved or resolved in % of patients<br> 3. Quality of life, measured by the quality of life questionnaire the Moorehead-Ardelt Quality of Life Questionnaire II<br><br> Follow-up for all treatment arms: 1, 3, 6, 12 months after the surgery<br>

Secondary Outcome Measures

Name	Time	Method
Postoperative morbidity